Cargando…
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients
BACKGROUND: Clozapine is an effective drug for the management of schizophrenia that has not responded to other agents, but some patients experience insufficient or adverse effects and discontinue treatment. OBJECTIVE: We investigated a potential association between clozapine serum concentrations and...
Autores principales: | Kyllesø, Lennart, Smith, Robert Løvsletten, Karlstad, Øystein, Andreassen, Ole A., Molden, Espen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408068/ https://www.ncbi.nlm.nih.gov/pubmed/34417726 http://dx.doi.org/10.1007/s40263-021-00847-4 |
Ejemplares similares
-
Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment: A Retrospective Pilot Study
por: Kyllesø, Lennart, et al.
Publicado: (2022) -
Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020) -
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020) -
Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020) -
Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)